Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension
Trenton E. Banks, Maheshinie Rajapaksha, Lihui Zhang, Feng Bai, Ning-Ping Wang, Zhi‐Qing Zhao
Topics & Concepts
LiraglutideEndocrinologyAngiotensin IIInternal medicineCardiac fibrosisNOX4LinagliptinNADPH oxidaseFibrosisDipeptidyl peptidase-4 inhibitorMedicineChemistryBlood pressureDiabetes mellitusType 2 diabetesOxidative stressCardiac Fibrosis and RemodelingNitric Oxide and Endothelin EffectsDiabetes Treatment and Management